EPIZYME INC (EPZM)
US29428V1044 - Common Stock
| TTM (2022-6-30) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | 2018 (2018-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -207.73M | -251.12M | -231.69M | -170.30M | -123.63M | |||
| Depreciation Amortization | 5.23M | 5.25M | 3.98M | 840.00K | 1.05M | |||
| Income Taxes - Deferred | N/A | 0.00 | 90.00K | 90.00K | 180.00K | |||
| Change In Working Capital | -19.36M | -156.00K | -8.04M | 7.13M | -9.65M | |||
| Interest Paid | 21.75M | 21.75M | 7.46M | N/A | N/A | |||
| Taxes Paid | N/A | 104.00K | 60.00K | 50.00K | 50.00K | |||
| Other non cash items | 13.26M | 19.18M | 29.32M | 15.07M | 10.45M | |||
| OPERATING CASH FLOW | -208.60M | -226.85M | -206.34M | -147.17M | -121.60M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -275.00K | -486.00K | -50.88M | -590.00K | -300.00K | |||
| Other Investing Activity | 89.62M | 125.97M | 36.29M | -84.73M | -102.31M | |||
| INVESTING CASH FLOW | 89.34M | 125.48M | -14.59M | -85.32M | -102.61M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | 0.00 | 195.00M | 24.98M | -130.00K | |||
| Stock Issued/Repurchased | 110.81M | 31.80M | 57.86M | 263.30M | 84.60M | |||
| Other Financing Activity | -645.00K | -308.00K | -3.20M | -1.93M | -260.00K | |||
| FINANCING CASH FLOW | 110.16M | 31.49M | 249.66M | 286.35M | 84.21M | |||
| CHANGE IN CASH | -9.10M | -69.88M | 28.73M | 53.86M | -140.00M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -208.60M | -226.85M | -206.34M | -147.17M | -121.60M | |||
| Capital Expenditure | -275.00K | -486.00K | -50.88M | -590.00K | -300.00K | |||
| FREE CASH FLOW | -208.88M | -227.34M | -257.22M | -147.76M | -121.90M | |||
All data in USD